ArticleBioengineering & translational medicine2024

Siglec15/TGF-β bispecific antibody mediates synergistic anti-tumor response against 4T1 triple negative breast cancer in mice.

Limei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.